Vimarsana
Biggest News Aggregation in the World

Page 7 - Science Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Science Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Science Ventures Today - Breaking & Trending Today

Phase Four Raises $26m Series B led by New Science Ventures - Vimarsana News

Phase Four Raises $26m Series B led by New Science Ventures

/PRNewswire/ -- Phase Four, the creator of the radio-frequency thruster for satellite propulsion, announced today that it has closed a Series B investment...

Satellite Propulsion Startup Phase Four Closes Series B Investment Round - Vimarsana News

Satellite Propulsion Startup Phase Four Closes Series B Investment Round

California-based startup Phase Four closed a $26 million Series B investment round on June 11 to advance the development of its Radio-Frequency Thruster (RFT) and plasma propulsion systems. Phase Four was founded in 2015 to provide advanced propulsion systems to satellite constellations. The company designed its RFT with an architecture that aims to lower the cost of manufacturing by using miniaturized power electronics, and being “propellant agnostic.” Global venture capital firm New Science Ventures LLC (NSV) led the Series B round. NSV manages an $800 million portfolio and operates a...

Jubilant Pharmova transfers NCDs aggregating Rs 100 cr in books of Jubilant Ingrevia - Vimarsana News

Jubilant Pharmova transfers NCDs aggregating Rs 100 cr in books of Jubilant Ingrevia

Pursuant to composite scheme of arrangementJubilant Pharmova announced that pursuant to the Composite Scheme of Arrangement amongst HSB Corporate Consultants, Jubilant Stock Holding, SSB Consultants & Management Services, JCPL Life Science Ventures and Holdings and JSPL Life Science Services and Holdings (collectively, the 'Transferor Companies'), Jubilant Pharmova (the 'Transferee Company' or the 'Demerged Company') and Jubilant Ingrevia (the 'Resulting Company') and their respective shareholders and creditors (the 'Composite Scheme'), Non-Convertible Debentures of Rs. 100 crore issued by t...

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million - Vimarsana News

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million

New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million Ventyx Biosciences combines clinical stage programs of three companies co-founded and merged by New Science Ventures News provided by Share this article Share this article NEW YORK and LONDON, March 9, 2021 /PRNewswire/ -- New Science Ventures LLC ("NSV"), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline of im...

IP Litigation 2020 Year In Review - Intellectual Property - Vimarsana News

IP Litigation 2020 Year In Review - Intellectual Property

Canmar 5 was a trend for a day or here to stay. This year, the Federal Court has seen increased attempts by litigants to resolve matters more expeditiously by way of dispositive motions. Summary judgment was granted in three cases 6 and two motions for default judgment were brought but dismissed based on insufficient evidence. ViiV Healthcare Company v. Gilead Sciences Canada, 8 the Court held that completion of discoveries is not a precondition to summary trial such that resolution may be sought at very early stages of the proceeding. We saw the Federal Court grant summary disposition to ...

Source: mondaq.com